|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 29.63 USD | +3.11% |
|
+3.57% | +12.53% |
| 10-27 | Zymeworks Inc. - Special Call | |
| 10-24 | Zymeworks Inc. Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate Zw191 At ESMO Congress 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYMEWORKS INC. | Bio Therapeutic Drugs | +3.11% | +3.57% | +12.53% | +80.01% | +28.27% | 2.1B |  |  | |
- Stock Market
- Stocks
- ZYME Stock
- Charts Zymeworks Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
